AMG 510 Ethnic Sensitivity Study (CodeBreaK 105).

Clinical trial NCT04380753 · COMPLETED

Trial details

NCT number: NCT04380753
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation

Start date: 2020-04-28
Primary completion: 2021-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.